StockpollyBeta
Get App
Delisting riskPopularity #4,270
TELA · NASDAQ · Medical - Devices

TELA Bio (TELA)

Reinforced tissue matrices for hernia and soft-tissue reconstruction.

$1.41
vs last close+0.00 (+0.35%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue151717161918192021211919
Cost of revenue555566667775
Gross profit101211111311131414141314
212416232220232322202323
Research & development232222322223
182121202018202119182121
Selling & marketing141718171614171715141716
General & administrative444444444444
Other expenses00−8000000000
Operating income−10−12−5−12−9−8−10−9−8−7−11−9
−1−1−1−1−1−1−1−1−1−2−2−2
Interest expense1111111112−22
Other non-operating income−1−10000000100
Income before tax−11−13−6−13−10−9−11−10−9−9−12−11
Income tax expense000000000000
Net income from continuing operations−11−13−6−13−10−9−11−10−9−9−12−11
Net income−11−13−6−13−10−9−11−10−9−9−12−11
EPS, basic−$0.45−$0.53−$0.23−$0.51−$0.42−$0.23−$0.25−$0.22−$0.19−$0.17−$0.21−$0.20
EPS, diluted−$0.45−$0.53−$0.23−$0.51−$0.42−$0.23−$0.25−$0.22−$0.19−$0.17−$0.21−$0.20
Weighted average shares, basic242425252540454545525757
Weighted average shares, diluted242425252540454545525757
EBITDA−9−11−4−11−9−8−10−8−7−7−10−9
Depreciation & amortization000000000000
EBIT−10−12−4−11−9−8−10−9−7−7−10−9